Long-term International Dual-Source Endometriosis and Adenomyosis Registry (LIDEA Registry)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/107378
• EU PAS number:
  EUPAS107377
• Study ID:
  107378
• Official title and acronym:
  Long-term International Dual-Source Endometriosis and Adenomyosis Registry (LIDEA Registry)
• DARWIN EU® study:
  No
• Study countries:
  France

  Germany

  Italy

  Spain

  United Kingdom

  United States
• Study description:
  This prospective registry focuses on people with a confirmed, or presumed diagnosis of the two common chronic gynecological diseases: endometriosis and adenomyosis. Longitudinal data will be collected from eligible study participants directly with the aim to better understand the course of endometriosis and adenomyosis. Specific focus will be applied to pelvic pain and quality of life outcomes under different treatment pathways as prescribed by health care practitioners in real-world clinical practice. The data collected for this registry will further contribute to knowledge generation and accelerate scientific innovation in the scientific community of endometriosis and adenomyosis.
• Study status:
  Planned

Research institutions and networks

Institutions

Berlin Center for Epidemiology & Health Research, ZEG Berlin

Germany

Study timelines

Date when funding contract was signed

Planned: 08/11/2022

Study start date

Planned: 31/01/2024

Date of final study report

Planned: 29/12/2023

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Organon LLC

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable